These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5506106)

  • 1. Altered reactivity to measles virus in previously vaccinated children.
    Gokiert JG; Beamish WE
    Can Med Assoc J; 1970 Oct; 103(7):724-7. PubMed ID: 5506106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological analysis of cases with rash and fever illness after measles vaccine inoculation during 1999 to 2002 in Shandong province, China].
    Xu AQ; Xu Q; Song LZ; Xiao ZK; Zhang L; Wang CY; Wang TZ; Li RP; Li MS; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):417-20. PubMed ID: 15231169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
    Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ
    Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reactions after MMR vaccination].
    Kaaber K; Samuelsson IS; Larsen SO
    Ugeskr Laeger; 1990 Jun; 152(23):1672-6. PubMed ID: 2363211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine.
    Scott TF; Bonanno DE
    N Engl J Med; 1967 Aug; 277(5):248-50. PubMed ID: 6029312
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-associated "wild-type" measles.
    Berggren KL; Tharp M; Boyer KM
    Pediatr Dermatol; 2005; 22(2):130-2. PubMed ID: 15804301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual clinical reactions to live measles vaccine in a child previously immunized with killed measles vaccine.
    Iwai T; Matumoto M; Kawana R
    Jpn J Exp Med; 1968 Apr; 38(2):139-42. PubMed ID: 5304930
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):493-9. PubMed ID: 4095612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 16. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Febrile exanthema following measles vaccination--risk of recurrence in the 2d measles vaccination?].
    Wiersbitzky S; Bruns R
    Kinderarztl Prax; 1991 Dec; 59(12):384-5. PubMed ID: 1774855
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with a measles vaccine manufactured in India.
    Shaikh N; Raut SK; Bedekar SS; Phadke MA; Banerjee K
    Indian Pediatr; 1992 Jul; 29(7):883-7. PubMed ID: 1428138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical measles syndrome: pathologic and serologic findings.
    Annunziato D; Kaplan MH; Hall WW; Ichinose H; Lin JH; Balsam D; Paladino VS
    Pediatrics; 1982 Aug; 70(2):203-9. PubMed ID: 7099785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S; Sanders RC; Alpers MP
    J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.